Who to follow: HealthTech executives
HE
Helmy Eltoukhy, PhD
Co-CEO · Guardant Health
DiagnosticsNorth AmericaLarge following
Why follow Helmy
Co-leads the company whose blood test now guides treatment selection for Lilly's Inluriyo combination.
Writes about
Liquid biopsyPrecision oncologyCompanion diagnostics
Best for
Readers following liquid biopsy and precision oncology.